Price
$0.3061
Decreased by -1.58%
Dollar Volume (20D)
193.42 K
ADR%
10.01
Shares Float
1.93 M
Shares Outstanding
7.15 M
Shares Short
61.97 K
Market Cap.
2.22 M
Beta
N/A
Price / Earnings
N/A
20D Range
0.3 0.42
50D Range
0.27 2.5
200D Range
0.27 12.48
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Feb 20, 24 0
Increased by +100%
-1.6
Increased by +100%
Nov 14, 23 -0.12
Increased by +44.29%
-0.09
Decreased by -30%
Jul 3, 23 -0.15
Increased by +69.39%
-0.1
Decreased by -50%
May 31, 23 -0.1
Increased by +92.59%
-0.1
Mar 1, 23 -0.17 -0.17
Nov 14, 22 -0.21 -0.12
Decreased by -75%
Aug 15, 22 -0.49 -0.11
Decreased by -345.45%
Jun 6, 22 -1.35 -
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 19.07 K
Increased by +4.63%
-998.01 K
Increased by +38.88%
Decreased by -5.23 K%
Increased by +41.58%
Jun 30, 23 25.47 K
Increased by +138.57%
-1.19 M
Increased by +76.49%
Decreased by -4.66 K%
Increased by +90.15%
Mar 31, 23 25.47 K
Increased by +182.18%
-1.18 M
Decreased by -7.68%
Decreased by -4.65 K%
Increased by +61.84%
Dec 31, 22 22.52 K
Increased by +88.03%
-1.33 M
Increased by +57.59%
Decreased by -5.91 K%
Increased by +77.44%
Sep 30, 22 18.22 K
Increased by +67.71%
-1.63 M
Increased by +44.7%
Decreased by -8.96 K%
Increased by +67.02%
Jun 30, 22 10.68 K
Decreased by -58.33%
-5.05 M
Decreased by -983.97%
Decreased by -47.3 K%
Decreased by -2.5 K%
Mar 31, 22 9.03 K
Decreased by -23.7%
-1.1 M
Decreased by -112.23%
Decreased by -12.18 K%
Decreased by -178.17%
Dec 31, 21 11.98 K
Increased by +20.11%
-3.14 M
Decreased by -517.98%
Decreased by -26.19 K%
Decreased by -414.53%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.